Pan-cancer analyses showed that CD148 expression negatively correlated with prognosis of multiple malignancies besides gastric cancer, including sarcoma, endometrial cancer, and renal clear cell carcinoma, with statistical significance (P < 0.05; Figure 1B). This evidence concerns the gene PTPRJ and gastric cancer.